Trailing-twelve-month (TTM) revenue is $3.96 Billion with a year-over-year growth of (9.89%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $780,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $1,842,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $189,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $1,149,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $3,962,700,000 |
Current P/S: $14,154,177,680 market capitalization ÷ $3,962,700,000 TTM revenue = 3.57x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.15B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:06:03.482Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Fund Management Fee | $1.6B | $1.7B | $2.1B | $2.1B | $2.2B | $2.4B |
| Incentive Fee | N/A | $49M | $64M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $1.8B | $5.4B | $2.6B | $1.3B | $4.1B | $3.3B |
| Asia Pacific | $525M | $718M | $275M | $356M |
$3.96B
$3.96 Billion
(9.89%)
vs. $4.40B a year ago (TTM)
+18.08%
5 Year compound annual growth rate
1 Year
(9.89%)
3 Year
+10.07%
5 Year
+18.08%
10 Year
+8.14%
15 Year
+0.74%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.90B | +$809.40M | +19.80% |
| 2024 | $4.09B | +$2.22B | +118.97% |
| 2023 | $1.87B | ($1.81B) | (49.23%) |
| 2022 | $3.68B | ($2.15B) | (36.86%) |
| 2021 | $5.82B | +$3.69B | +172.87% |
| 2020 |
TTM Growth
(9.89%)
3-Year CAGR
+10.07%
5-Year CAGR
+18.08%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $134M |
| $197M |
| Performance Allocations | N/A | $6.1B | $1.3B | -$4M | $2.0B | $1.2B |
|---|
| Principal Investment Income (Loss) | N/A | $666M | $571M | $160M | $268M | $119M |
|---|
| Segment Reconciling Items | $418M | -$3.2B | -$274M | -$192M | N/A | N/A |
|---|
| Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment | N/A | N/A | N/A | N/A | -$168M | $290M |
|---|
| $47M |
| EMEA | $622M | $2.6B | $1.6B | $1.3B | $1.0B | $1.5B |
|---|
| $2.13B |
| ($782.20M) |
| (26.82%) |
| 2019 | $2.92B | +$861.00M | +41.89% |
| 2018 | $2.06B | ($720.90M) | (25.97%) |
| 2017 | $2.78B | +$842.00M | +43.53% |
| 2016 | $1.93B | ($1.43B) | (42.43%) |
